| Literature DB >> 593414 |
Abstract
The author gives a breakdown of costs for industrial drug research and development of seven German drug companies. Trends of development and fields of interdisciplinary pharmaceutical research are described. Increasing expenditures and requirements for safety and efficacy reduce the chances of innovation.Mesh：
Year: 1977 PMID： 593414 DOI： 10.1007/bf00440091
Source DB: PubMed Journal: Naturwissenschaften ISSN： 0028-1042